Nonadjunctive use of continuous glucose monitoring for diabetes treatment decisions

Journal of Diabetes Science and Technology

Volumn 10, Issue 5, 2016, Pages 1169-1173

  Castle, Jessica R ^a   Jacobs, Peter G ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Oregon Health and Science University Department of Biomedical Engineering   (United States)

Author keywords

Artificial pancreas; Continuous glucose monitoring; Type 1 diabetes

Indexed keywords

BLOOD GLUCOSE MONITORING; CLINICAL TRIAL (TOPIC); DECISION MAKING; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; SELF MONITORING; TREATMENT OUTCOME; ANALYSIS; BLOOD; GLUCOSE BLOOD LEVEL; PROCEDURES; TRENDS;

GLUCOSE BLOOD LEVEL;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HUMANS;

EID: 85012980073     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296816631569     Document Type: Review

References (38)

1. Tack C, Pohlmeier H, Behnke T, et al. Accuracy evaluation of five blood glucose monitoring systems obtained from the pharmacy: a European multicenter study with 453 subjects. Diabetes Technol Ther. 2012;14:330-337.
2. Boettcher C, Dost A, Wudy SA, et al. Accuracy of blood glucose meters for self-monitoring affects glucose control and hypoglycemia rate in children and adolescents with type 1 diabetes. Diabetes Technol Ther. 2015;17:275-282.
3. Hirose T, Mita T, Fujitani Y, Kawamori R, Watada H. Glucose monitoring after fruit peeling: pseudohyperglycemia when neglecting hand washing before fingertip blood sampling: wash your hands with tap water before you check blood glucose level. Diabetes Care. 2011;34:596-597.
4. Ginsberg BH. Factors affecting blood glucose monitoring: sources of errors in measurement. J Diabetes Sci Technol. 2009;3:903-913.
5. Karon BS, Griesmann L, Scott R, et al. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters. Diabetes Technol Ther. 2008;10:111-120.
6. Miller KM, Foster NC, Beck RW, et al. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015;38:971-978.
7. Polonsky WH, Fisher L, Hessler D, Edelman SV. What is so tough about self-monitoring of blood glucose? Perceived obstacles among patients with Type 2 diabetes. Diabet Med. 2014;31:40-46.
8. G5 mobile continuous glucose monitoring system user guide. Available at: http://www.dexcom.com/sites/dexcom.com/files/international/user-guides/G5-Mobile-UG-OUS-Eng-mmol.pdf. Accessed November 18, 2015.
9. Enlite glucose sensor user guide. Available at: http://www.medtronicdiabetes.com/sites/default/files/library/downloadlibrary/user-guides/Mp6025676-2AF1-a-pdf.pdf. Accessed November 18, 2015.
10. Kamath A, Mahalingam A, Brauker J. Analysis of time lags and other sources of error of the DexCom SEVEN continuous glucose monitor. Diabetes Technol Ther. 2009;11:689-695.
11. Helton KL, Ratner BD, Wisniewski NA. Biomechanics of the sensor-tissue interface-effects of motion, pressure, and design on sensor performance and foreign body response-part II: examples and application. J Diabetes Sci Technol. 2011;5:647-656.
12. Ward WK. A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis. J Diabetes Sci Technol. 2008;2:768-777.
13. Basu A, Dube S, Slama M, et al. Time lag of glucose from intravascular to interstitial compartment in humans. Diabetes. 2013;62:4083-4087.
14. Basu A, Dube S, Veettil S, et al. Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes. J Diabetes Sci Technol. 2015;9:63-68.
15. Ward WK, Engle JM, Branigan D, El Youssef J, Massoud RG, Castle JR. The effect of rising vs. falling glucose level on amperometric glucose sensor lag and accuracy in type 1 diabetes. Diabet Med. 2012;29:1067-1073.
16. Keenan DB, Mastrototaro JJ, Voskanyan G, Steil GM. Delays in minimally invasive continuous glucose monitoring devices: a review of current technology. J Diabetes Sci Technol. 2009;3:1207-1214.
17. Maahs DM, De Salvo D, Pyle L, et al. Effect of acetaminophen on CGM glucose in an outpatient setting. Diabetes Care. 2015;38:e158-e159.
18. Wong JC, Foster NC, Maahs DM, et al. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014;37:2702-2709.
19. Polonsky WH, Hessler D. Perceived accuracy in continuous glucose monitoring: understanding the impact on patients. J Diabetes Sci Technol. 2015;9:339-341.
20. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011;34:795-800.
21. Edelman SV, Bailey TS. Continuous glucose monitoring health outcomes. Diabetes Technol Ther. 2009;11(suppl 1):S68-74.
22. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, et al. Continuous glucose monitoring and intensive treatment of type 1. diabetes. N Engl J Med. 2008;359:1464-1476.
23. Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363:311-320.
24. Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012;55:3155-3162.
25. Pettus J, Price DA, Edelman SV. How patients with type 1 diabetes translate continuous glucose monitoring data into diabetes management decisions. Endocr Pract. 2015;21:613-620.
26. Kovatchev BP, Patek SD, Ortiz EA, Breton MD. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring. Diabetes Technol Ther. 2015;17:177-186.
27. Wilinska ME, Hovorka R. Glucose control in the intensive care unit by use of continuous glucose monitoring: what level of measurement error is acceptable? Clin Chem. 2014;60:1500-1509.
28. Bailey TS, Chang A, Christiansen M. Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm. J Diabetes Sci Technol. 2015;9:209-214.
29. Bergenstal RM, Klonoff DC, Garg SK, et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med. 2013;369:224-232.
30. Jacobs PG, El Youssef J, Castle J, et al. Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies. IEEE Trans Biomed Eng. 2014;61:2569-2581.
31. Jacobs PG, Resalat N, El Youssef J, et al. Incorporating an exercise detection, grading, and hormone dosing algorithm into the artificial pancreas using accelerometry and heart rate. J Diabetes Sci Technol. 2015;9:1175-1184.
32. Haidar A, Legault L, Messier V, Mitre TM, Leroux C, Rabasa-Lhoret R. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Lancet Diabetes Endocrinol. 2015;3:17-26.
33. Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014;371:313-325.
34. Kovatchev BP, Renard E, Cobelli C, et al. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care. 2014;37:1789-1796.
35. Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013;368:824-833.
36. Thabit H, Tauschmann M, Allen JM, et al. Home use of an artificial beta cell in type 1 diabetes. N Engl J Med. 2015;373: 2129-2140.
37. Kowalski A. Pathway to artificial pancreas systems revisited: moving downstream. Diabetes Care. 2015;38:1036-1043.
38. American Diabetes Association. 5. Glycemic targets. Diabetes Care. 2016;39(suppl 1):S39-S46.